Annual FCF
-$95.23 M
-$64.54 M-210.25%
December 31, 2023
Summary
- As of February 18, 2025, PSTX annual free cash flow is -$95.23 million, with the most recent change of -$64.54 million (-210.25%) on December 31, 2023.
- During the last 3 years, PSTX annual FCF has risen by +$35.00 million (+26.88%).
Performance
PSTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$10.24 M
-$47.67 M-127.35%
September 30, 2024
Summary
- As of February 18, 2025, PSTX quarterly free cash flow is -$10.24 million, with the most recent change of -$47.67 million (-127.35%) on September 30, 2024.
- Over the past year, PSTX quarterly FCF has stayed the same.
Performance
PSTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$17.13 M
-$17.34 M-8178.30%
September 30, 2024
Summary
- As of February 18, 2025, PSTX TTM free cash flow is -$17.13 million, with the most recent change of -$17.34 million (-8178.30%) on September 30, 2024.
- Over the past year, PSTX TTM FCF has stayed the same.
Performance
PSTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PSTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -210.3% | 0.0% | 0.0% |
| 3 y3 years | +26.9% | 0.0% | 0.0% |
| 5 y5 years | -142.3% | 0.0% | 0.0% |
PSTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +210.2% | +10.4% | -117.0% | +408.5% | -8178.3% | +635.7% |
| 5 y | 5-year | +210.2% | +36.8% | -117.0% | +408.5% | -8178.3% | +751.9% |
| alltime | all time | +315.9% | +36.8% | -117.0% | +408.5% | -8178.3% | +751.9% |
Poseida Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.24 M(-127.4%) | -$17.13 M(-8178.3%) |
| Jun 2024 | - | $37.43 M(-345.2%) | $212.00 K(-100.3%) |
| Mar 2024 | - | -$15.27 M(-47.5%) | -$71.71 M(-24.7%) |
| Dec 2023 | -$95.23 M(+210.2%) | -$29.05 M(-509.3%) | -$95.23 M(+48.7%) |
| Sep 2023 | - | $7.10 M(-120.6%) | -$64.04 M(+484.2%) |
| Jun 2023 | - | -$34.49 M(-11.1%) | -$10.96 M(-37.1%) |
| Mar 2023 | - | -$38.79 M(-1910.0%) | -$17.42 M(-43.3%) |
| Dec 2022 | -$30.70 M(-70.8%) | $2.14 M(-96.4%) | -$30.70 M(+24.9%) |
| Sep 2022 | - | $60.17 M(-247.0%) | -$24.58 M(-80.5%) |
| Jun 2022 | - | -$40.95 M(-21.4%) | -$125.99 M(+7.0%) |
| Mar 2022 | - | -$52.07 M(-730.4%) | -$117.71 M(+11.9%) |
| Dec 2021 | -$105.18 M | $8.26 M(-120.0%) | -$105.18 M(-27.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$41.24 M(+26.2%) | -$145.90 M(+6.7%) |
| Jun 2021 | - | -$32.67 M(-17.4%) | -$136.79 M(-4.6%) |
| Mar 2021 | - | -$39.53 M(+21.8%) | -$143.37 M(+10.1%) |
| Dec 2020 | -$130.24 M(+86.9%) | -$32.47 M(+1.1%) | -$130.24 M(+12.5%) |
| Sep 2020 | - | -$32.13 M(-18.1%) | -$115.72 M(+10.7%) |
| Jun 2020 | - | -$39.24 M(+48.6%) | -$104.58 M(+28.9%) |
| Mar 2020 | - | -$26.40 M(+47.1%) | -$81.15 M(+16.5%) |
| Dec 2019 | -$69.67 M(+77.3%) | -$17.95 M(-14.5%) | -$69.67 M(+34.7%) |
| Sep 2019 | - | -$20.99 M(+32.8%) | -$51.72 M(+68.3%) |
| Jun 2019 | - | -$15.81 M(+5.9%) | -$30.74 M(+105.9%) |
| Mar 2019 | - | -$14.93 M | -$14.93 M |
| Dec 2018 | -$39.30 M(+71.6%) | - | - |
| Dec 2017 | -$22.90 M | - | - |
FAQ
- What is Poseida Therapeutics annual free cash flow?
- What is the all time high annual FCF for Poseida Therapeutics?
- What is Poseida Therapeutics annual FCF year-on-year change?
- What is Poseida Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly FCF year-on-year change?
- What is Poseida Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Poseida Therapeutics?
- What is Poseida Therapeutics TTM FCF year-on-year change?
What is Poseida Therapeutics annual free cash flow?
The current annual FCF of PSTX is -$95.23 M
What is the all time high annual FCF for Poseida Therapeutics?
Poseida Therapeutics all-time high annual free cash flow is -$22.90 M
What is Poseida Therapeutics annual FCF year-on-year change?
Over the past year, PSTX annual free cash flow has changed by -$64.54 M (-210.25%)
What is Poseida Therapeutics quarterly free cash flow?
The current quarterly FCF of PSTX is -$10.24 M
What is the all time high quarterly FCF for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly free cash flow is $60.17 M
What is Poseida Therapeutics quarterly FCF year-on-year change?
Over the past year, PSTX quarterly free cash flow has changed by $0.00 (0.00%)
What is Poseida Therapeutics TTM free cash flow?
The current TTM FCF of PSTX is -$17.13 M
What is the all time high TTM FCF for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM free cash flow is $212.00 K
What is Poseida Therapeutics TTM FCF year-on-year change?
Over the past year, PSTX TTM free cash flow has changed by $0.00 (0.00%)